Related references
Note: Only part of the references are listed.Molecular surveillance of Pfcrt and k13 propeller polymorphisms of imported Plasmodium falciparum cases to Zhejiang Province, China between 2016 and 2018
Xiaoxiao Wang et al.
MALARIA JOURNAL (2020)
A Kelch13-defined endocytosis pathway mediates artemisinin resistance in malaria parasites
Jakob Birnbaum et al.
SCIENCE (2020)
Detection of mutations associated with artemisinin resistance at k13-propeller gene and a near complete return of chloroquine susceptible falciparum malaria in Southeast of Tanzania
George M. Bwire et al.
SCIENTIFIC REPORTS (2020)
Local emergence in Amazonia of Plasmodium falciparum k13 C580Y mutants associated with in vitro artemisinin resistance
Luana C. Mathieu et al.
ELIFE (2020)
K13-propeller gene polymorphisms in Plasmodium falciparum parasite population in malaria affected countries: a systematic review of prevalence and risk factors
Moses Ocan et al.
MALARIA JOURNAL (2019)
Efficacy of artemether-lumefantrine versus dihydroartemisinin-piperaquine for the treatment of uncomplicated malaria among children in Rwanda: an open-label, randomized controlled trial
Aline Uwimana et al.
TRANSACTIONS OF THE ROYAL SOCIETY OF TROPICAL MEDICINE AND HYGIENE (2019)
Contribution of Functional Antimalarial Immunity to Measures of Parasite Clearance in Therapeutic Efficacy Studies of Artemisinin Derivatives
Katherine O'Flaherty et al.
JOURNAL OF INFECTIOUS DISEASES (2019)
Evolution and expansion of multidrug-resistant malaria in southeast Asia: a genomic epidemiology study
William L. Hamilton et al.
LANCET INFECTIOUS DISEASES (2019)
Antimalarial drug resistance in Africa: the calm before the storm?
Melissa D. Conrad et al.
LANCET INFECTIOUS DISEASES (2019)
Determinants of dihydroartemisinin-piperaquine treatment failure in Plasmodium falciparum malaria in Cambodia, Thailand, and Vietnam: a prospective clinical, pharmacological, and genetic study
Rob W. van der Pluijm et al.
LANCET INFECTIOUS DISEASES (2019)
Protozoan persister-like cells and drug treatment failure
Michael P. Barrett et al.
NATURE REVIEWS MICROBIOLOGY (2019)
Plasmodium falciparum resistance to piperaquine driven by PfCRT
Satish K. Dhingra et al.
LANCET INFECTIOUS DISEASES (2019)
Association of mutations in the Plasmodium falciparum Kelch13 gene (Pf3D7_1343700) with parasite clearance rates after artemisinin-based treatmentsa WWARN individual patient data meta-analysis
Chanaki Amaratunga et al.
BMC MEDICINE (2019)
Origins of the current outbreak of multidrug-resistant malaria in southeast Asia: a retrospective genetic study
Roberto Amato et al.
LANCET INFECTIOUS DISEASES (2018)
Implications of population-level immunity for the emergence of artemisinin-resistant malaria: a mathematical model
Nick Scott et al.
MALARIA JOURNAL (2018)
Emerging Southeast Asian PfCRT mutations confer Plasmodium falciparum resistance to the first-line antimalarial piperaquine
Leila S. Ross et al.
NATURE COMMUNICATIONS (2018)
The spread of artemisinin-resistant Plasmodium falciparum in the Greater Mekong subregion: a molecular epidemiology observational study
Mallika Imwong et al.
LANCET INFECTIOUS DISEASES (2017)
Genetic markers associated with dihydroartemisinin-piperaquine failure in Plasmodium falciparum malaria in Cambodia: a genotype-phenotype association study
Roberto Amato et al.
LANCET INFECTIOUS DISEASES (2017)
A surrogate marker of piperaquine-resistant Plasmodium falciparum malaria: a phenotype-genotype association study
Benoit Witkowski et al.
LANCET INFECTIOUS DISEASES (2017)
Antimalarial drug resistance: linking Plasmodium falciparum parasite biology to the clinic
Benjamin Blasco et al.
NATURE MEDICINE (2017)
Antimalarial Drug Resistance: A Threat to Malaria Elimination
Didier Menard et al.
COLD SPRING HARBOR PERSPECTIVES IN MEDICINE (2017)
Assessing the potential impact of artemisinin and partner drug resistance in sub-Saharan Africa
Hannah C. Slater et al.
MALARIA JOURNAL (2016)
A Worldwide Map of Plasmodium falciparum K13-Propeller Polymorphisms
D. Menard et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
Genomic epidemiology of artemisinin resistant malaria
Roberto Amato et al.
ELIFE (2016)
Surveillance of Artemisinin Resistance in Plasmodium falciparum in India Using the kelch13 Molecular Marker
Neelima Mishra et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2015)
Clinical determinants of early parasitological response to ACTs in African patients with uncomplicated falciparum malaria: a literature review and meta-analysis of individual patient data
Salim Abdulla et al.
BMC MEDICINE (2015)
Genetic architecture of artemisinin-resistant Plasmodium falciparum
Olivo Miotto et al.
NATURE GENETICS (2015)
K13-propeller mutations confer artemisinin resistance in Plasmodium falciparum clinical isolates
Judith Straimer et al.
SCIENCE (2015)
A molecular marker of artemisinin-resistant Plasmodium falciparum malaria
Frederic Ariey et al.
NATURE (2014)
Spread of Artemisinin Resistance in Plasmodium falciparum Malaria
E. A. Ashley et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Novel phenotypic assays for the detection of artemisinin-resistant Plasmodium falciparum malaria in Cambodia: in-vitro and ex-vivo drug-response studies
Benoit Witkowski et al.
LANCET INFECTIOUS DISEASES (2013)
Global malaria connectivity through air travel
Zhuojie Huang et al.
MALARIA JOURNAL (2013)
Global malaria mortality between 1980 and 2010: a systematic analysis
Christopher J. L. Murray et al.
LANCET (2012)
Artemisinin Resistance in Plasmodium falciparum Malaria.
Arjen M. Dondorp et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Decreasing pfmdr1 copy number in Plasmodium falciparum malaria heightens susceptibility to mefloquine, lumefantrine, halofantrine, quinine, and artemisinin
Amar Bir Singh Sidhu et al.
JOURNAL OF INFECTIOUS DISEASES (2006)
Share Paper
